The aim of this study was to determine the survival rate of patients with non-small cell lung cancer (NSCLC) who were preoperatively diagnosed with a negative N2 lymph node, but postoperatively confirmed as a positive N2 node based on a pathological evaluation. Materials and Methods: The hospital records of 248 patients from 1994 to 2009 with resected primary NSCLC who were preoperatively diagnosed with negative N2 lymph node, were retrospectively reviewed. Of these, after surgery, there were 148 (59.7%) patients with pathological N0, 54 (21.8%) with pathological N1 and 46 (18.5%) with pathological N2. Results: The median follow-up period was 24 months (range, 1 to 132 months). The 5-year disease free survival rates were 60% in pN0, 44% in pN1, and 29% in pN2. The 5-year overall survival rates were 63.1% in pN0, 51.9% in pN1, and 33.5% in pN2. There were no statistically significant differences between pN1 and pN2 (p=0.326 and p=0.106, respectively). Thirty-three (71.7%) of the 46 pN2 patients had single-zone metastasis, and 13 patients (28.3%) had multiple-zone metastases over the two nodal zone metastasis. There were no statistical differences in the 5-year disease free survival rate and the 5-year overall survival rates between the two groups. Conclusion: The 5-year disease free survival and the overall survival rate of the patients with unsuspected N2 disease were statistically similar with that of the patients with pathological N1 disease. There was no statistically significant difference between the patients with a single-zone metastasis and a multiple zone metastasis.
INTRODUCTION
Mediastinal nodal involvement is generally considered to be one of the most important prognostic factors in patients with non-small cell lung cancer (NSCLC). In patients with N2 disease, identified preoperatively, pulmonary resection is not recommended by the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [1] .
However, the optimal treatment approach for clinical stage IIIA has been controversial, because N2 disease is defined just as the presence of metastasis in the ipsilateral mediastinal lymph node by the 7th American Joint Committee on Cancer tumor-node-metastasis (AJCC/TNM) staging for lung cancer [2] . Stage IIIA NSCLC, especially N2 disease, shows a broad spectrum of the disease. Several published reports have suggested that there were significant variabilities of the long Deok Heon Lee, et al − 50 − term outcomes, according to the heterogeneity of N2 disease, such as a single N2 disease versus a multiple N2 disease, skip metastasis (negative N1 and positive N2 disease), the number of positive N2 disease, and unsuspected, occult or incidental N2 disease [3] [4] [5] [6] [7] [8] [9] [10] [11] .
Recently, the nodal zone concept was proposed as a new descriptor of the intrathoracic lymph node by International Association for the Study of Lung Cancer (IASLC) [12] . The lymph node maps, which have been widely used for several decades, were classified by Mountain and Dressler [13] , Naruke [14] , and Naruke et al. [15] . However, there are several discrepancies in the definition of the nomenclature between the two classifications. The nodal zone concept was proposed as able to achieve uniformity, an accurate assessment of lymph node involvement, and to promote future analyses of a planned prospective international database.
The purpose of this study is to investigate the long term outcomes for patients with unsuspected N2 (negative N2 disease on the preoperative diagnosis, but positive N2 disease on the postoperative pathologic diagnosis) disease, and to identify the effects of the 'nodal zone' relationship to the long-term outcomes of unsuspected N2 disease. The patients were followed up every 3 months for the first 2 years after surgery, and every 6 months thereafter. The chest radiographs were obtained during every follow-up, and CT was obtained every 6 months for the first two years, and annually thereafter. Other specific studies, such as a PET-CT scan, brain MRI, a whole body bone scan, or bronchoscopy were performed for selected patients during the follow-up period.
MATERIALS AND METHODS
All statistical analyses were carried out with the statistical software SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA).
Continuous data were presented as the mean and standard deviation, and the discrete data were presented as a number and percentage. The association between the data was analyzed using the independent t-test or the Mann-Whitney U-test for continuous variables, and the Pearson's χ 2 test or Fisher's exact test was used for the discrete variables. The disease free survival was defined as the period of staying free from Unsuspected N2 Disease in Non-Small Cell Lung Cancer Values are presented as mean±standard deviation or number (%). TNM, tumor-node-metastasis. disease after surgery. The confirmed loco-regional recurrences, distant metastases, and deaths were used as the specific events for disease free survival. The overall survival was defined as the duration from the operation to death from any cause. The survival rates were derived using the Kaplan-Meier method, and the differences between the subgroups were assessed using the log-rank test. The multivariate analysis of the survival influence was performed using a Cox proportional hazards model. A statistically significant difference was defined as a p-value of less than two-sided 0.05. The institutional review board of the University of Keimyung in South Korea approved this study.
RESULTS
There were 248 patients who met the inclusion and exclusion criteria of this study. The 5-year disease free survival rates were 60.4% in the pN0 group, 44.1% in the pN1 group, and 29.4% in the pN2 group. The disease free survival rate was significantly better in the pN0 group than in that of the pN1 or pN2 group (p=0.030 and p=0.000, respectively). However, there was no statistically significant differences between the pN1 and pN2 groups (p=0.326). The 5-year overall survival rates were 63.1% in the pN0 group, 51.9% in the pN1 group, and 33.5% in the pN2 group. The overall survival was significantly better in the pN0 group than in that of the pN2 group (p＜0.000). However, there was no statistically significant differences between the pN0 and pN1 group (p=0.088), and between the pN1 and pN2 groups (p=0.106) (Fig. 1) .
The 5-year disease free survival rates were 29.5% in the single-zone metastasis group and 28.0% in the multiple-zone metastasis group (p=0.635). The 5-year overall survival rates were 35.1% in the single-zone metastasis group and 30.8% in the multiple-zone metastasis group (p=0.857). There were no statistical differences between the two groups. Although ipsilateral mediastinal lymph node metastasis has been considered by most physicians to have a poor long-term prognosis, it has been reported that the long-term prognosis of N2 disease varies depending on the extent of mediastinal lymph node metastasis.
In the present study, we did not principally perform a surgical resection in N2 disease suspected preoperatively.
However, the incidence of unsuspected N2 disease after surgical resection was 18.5%. The patients' 5-years survival rate and 5-year disease free survival rate were 33.5% and 29.4%, respectively.
De Leyn et al. [16] reported that the incidence of unsuspected N2 disease was 14.5% in the patients who underwent surgery for NSCLC, and the 5-year survival rate of the patients with unsuspected N2 disease was 22%. Cerfolio and
Bryant [8] reported that the 5-year survival rate was 35% in the patients with unsuspected N2 disease who underwent complete resection and adjuvant therapy. Ohta et al. [7] reported that the 5-year and 10-year survival rates were 27%
and 12%, respectively, in 94 patients with NSCLC and single-level N2 disease who underwent an initial operation.
Misthos et al. [10] suggested that patients with one-station mediastinal lymph node metastasis, who undergo surgery, have a good prognosis.
The wide extent of lymph node involvement tends to have a worse prognosis than the limited extent of nodal metastasis [3, 4, 9, 17, 18] . It is necessary to accurately designate each nodal station for an exact nodal assessment. However, strict preor intra-operative mapping of the nodal station might have been difficult and confusing. The two different lymph node classifications of Mountain and Dressler [13] , Naruke [14] , and Naruke et al. [15] have been widely used for the past three decades in Western and Asian countries. There have been some mediastinal lymph nodes mapping discrepancies between the two nodal classifications. In addition, it might be difficult or equivocal that the nodal station was decided exactly because of the continuity of each nodal station, especially in the cases of subcarinal lymph nodes and hilar lymph nodes, or upper paratracheal nodes and lower paratracheal nodes. To resolve these matters, a new concept named 'nodal zone' was recently proposed by IASLC [12] .
In this study, single nodal zone metastasis occurred in two-thirds of the patients with unsuspected N2 disease, and multiple nodal zone metastasis occurred in one-third of the patients. There were no statistical differences in the overall survival rate and disease-free survival rate between the two Deok Heon Lee, et al
groups. However, the number of patients with N2 disease may have been too small to conclude statistical significance in our study. Further analysis with a larger population will be needed for a reliable conclusion on the long-term survival between these two groups. Kim et al. [19] analyzed the survival data of 217 patients with ipsilateral mediastinal metastasis of their 1,186 patients with NSCLC, who underwent curative surgical resection. They reported that patients with single nodal zone metastasis showed favorable outcomes compared with that of the group with multiple nodal zone metastases [19] . Takamochi et al. [20] reported that there were statistically significant differences between a single station N2 and a multiple station N2, but there was no statistical significance between a single zone N2 and a multiple zone N2. They also suggested that the survival differences between the different zones were not statistically significant within each pathological N stage [20] .
This study has some limitations. First, an unrecognized selection bias might be present because this study is a retrospective analysis. Second, the population of the study is relatively small, especially the population of unsuspected N2 disease (n=46), which may reduce the statistical power for detecting the difference of the overall survival rate and disease free survival rate. Finally, the study period was relatively long (15 years). There have been many changes during the study period such as in the preoperative diagnostic principle and the perioperative and postoperative techniques. The accuracy of the preoperative diagnosis might be different because the PET-CT scan was only applied in the last 3 years of the study period.
CONCLUSION
In conclusion, although the statistical power is weak because of the small number of each subgroup, we may conclude the following: the 5-year disease free survival and overall survival rate of patients with unsuspected N2 disease, who underwent complete resection, was statistically similar with that of pN1 disease in this study.
